Original Research
Published on 01 Mar 2022
Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
in Metabolic Physiology
Frontiers in Physiology
doi 10.3389/fphys.2022.817542
- 8,147 views
- 14 citations




